Authors
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
Parafoveal retinal vessel density assessment by OCTA in healthy eyesStudy aims to identify methodology for least amount of variation, greatest test-retest reliability
Latest:
CTS 2025: Christine Kay, MD, on OPGx-LCA5 clinical results translated into real-life changesPhase 1/2 interim results highlight real-world functional enhancements in patients with severe LCA5-related Leber congenital amaurosis.
Latest:
The subthreshold laser’s role in retinal vascular diseaseCombination therapy benefits from laser in the mix for DME, other conditions
Latest:
Laser therapy may offer fast-acting option for CSR resolutionPatients tolerate therapy well; high safety profile allows re-treatment as necessary
Latest:
Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + LombBausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.
Latest:
Comparing suitable naïve versus pre-treated DME patientsJavier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.
Latest:
ARVO 2025: Rishi Singh, MD, discusses real-world clinical outcomes in patients with DMEIn an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab.
Latest:
FISH in focus for fast eye infection diagnosisDespite cost, advantages include sensitivity, improved outcomes
Latest:
ST laser therapy may reduce DME intravitreal injectionsUsed as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.
